HMA-EMA Network Data Steering Group: membership list
Submitted by Anonymous (not verified) on 10 July 2026 - 14:40
HMA-EMA Network Data Steering Group: membership list
Scientific recommendations on classification of advanced therapy medicinal products
Submitted by Anonymous (not verified) on 10 July 2026 - 14:40
Scientific recommendations on classification of advanced therapy medicinal products
Coding of indications in the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)
Submitted by Anonymous (not verified) on 10 July 2026 - 14:40
Coding of indications in the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)
Human medicines European public assessment report (EPAR): Vaxchora, cholera vaccine, oral, live, Date of authorisation: 01/04/2020, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 10 July 2026 - 14:32
Human medicines European public assessment report (EPAR): Vaxchora, cholera vaccine, oral, live, Date of authorisation: 01/04/2020, Revision: 11, Status: Authorised
CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025) and EMANS 2028 Strategic Overview (Theme 4)
Submitted by Anonymous (not verified) on 10 July 2026 - 14:30
CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025) and EMANS 2028 Strategic Overview (Theme 4)
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Submitted by Anonymous (not verified) on 10 July 2026 - 14:30
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Antimicrobial resistance in veterinary medicine
Submitted by Anonymous (not verified) on 10 July 2026 - 14:30
Antimicrobial resistance in veterinary medicine
Cardiac valves - Notified Body 0344 - 20/12/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Submitted by Anonymous (not verified) on 10 July 2026 - 14:29
Cardiac valves - Notified Body 0344 - 20/12/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Female contraceptive - Notified Body 0123 - 08/05/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Submitted by Anonymous (not verified) on 10 July 2026 - 14:27
Female contraceptive - Notified Body 0123 - 08/05/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Human medicines European public assessment report (EPAR): Olazax, olanzapine, Date of authorisation: 11/12/2009, Revision: 14, Status: Authorised
Submitted by Anonymous (not verified) on 10 July 2026 - 14:15
Human medicines European public assessment report (EPAR): Olazax, olanzapine, Date of authorisation: 11/12/2009, Revision: 14, Status: Authorised